Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This is an observational study with a drug called Nebido, a new testosterone replacement
therapy, which is available for the treatment of male hypogonadism. The benefit and safety of
Nebido have already been thoroughly evaluated through well controlled clinical trials. The
main purpose of this observational study is to confirm the established safety profile of
Nebido in daily clinical practice.